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ABSTRACT Oligomeric intermediates are possible cytotoxic species in diseases associated with amyloid deposits. Under-
standing the early steps of ﬁbril formation at atomic details may provide useful information for the rational therapeutic design. In
this study, using the heptapeptide GNNQQNY from the yeast prion-like protein Sup35 as a model system, for which a detailed
atomic structure of the ﬁbril formed has been determined by x-ray microcrystallography, we investigated its oligomer-formation
process from monomer to tetramer at the atomistic level by means of a molecular dynamics simulation with explicit water.
Although the number of simulations was limited, the qualitative statistical data gave some interesting results, which indicated that
the oligomer formation might start from antiparallel b-sheet-like dimers. When a new single peptide strand was added to the
preformed dimers to form trimers and then tetramers, the transition time from disorder aggregates to regular ones for the parallel
alignment was found to be obviously much less than for the antiparallel one. Moreover, the parallel pattern also statistically stayed
longer, providing more chances for oligomer extending, although the number of parallel stack events was almost equal to
antiparallel ones. Therefore, our simulations showed that new strands might prefer to extend in a parallel arrangement to form
oligomers, which agrees with the microcrystal structure of the amyloid ﬁbril formed by this peptide. In addition, analysis of the p-p
stacking of aromatic residues showed that this type of interaction did not play an important role in giving directionality for b-strand
alignment but played a great inﬂuence on stabilizing the structures formed in the oligomer-formation process.
INTRODUCTION
Amyloid ﬁbrils are highly ordered protein aggregates which
are associated with pathologies like Alzheimer’s disease,
Parkinson’s disease, type II diabetes, and transmissible
spongiform encephalopathies (1–4). Moreover, it has been
known that many proteins with unknown pathogenic roles
and some designed or synthetic peptides could also form
amyloid ﬁbrils under appropriate conditions (5–9). Although
these amyloidogenic proteins do not share any sequence
homology or common fold structure, they exhibit a remark-
ably similar cross b structure, with b-sheet backbones per-
pendicular to and hydrogen bonds parallel to the ﬁbril
axis (1,3). These imply that the underlying physical mech-
anisms of the assembling process may be common to all
amyloidogenic proteins. Recent experiments demonstrated
that soluble oligomeric intermediates are more toxic than
fully formed mature amyloid ﬁbrils (10–12). Thus designing
drugs that can prevent the formation of oligomeric interme-
diates or make them unstable and turn to mature ﬁbril fast is a
major concern in drug discovery against related diseases.
However, although great progress has been made on the in-
vestigation of amyloid ﬁbril-formation mechanisms (13–17),
including those efforts of the advent of amyloid inhibitors
(18,19), how the amyloidogenic proteins form oligomers and
the mechanism of their toxicity are still elusive.
Due to the noncrystalline and insoluble nature of the
amyloid ﬁbrils, it is difﬁcult to determine their atomic
resolution structure experimentally. Until recently, only a
few of them have been attained by the x-ray microcrys-
tallography data (20,21), by quenched hydrogen-deuterium
exchange NMR together with pairwise mutagenesis (22),
or by combing a range of biophysical techniques including
ﬂuorescence and NMR spectroscopy (23). On the other
hand, many short peptides displayed the same amyloid
properties as full-length polypeptides, such as GNNQQNY
from the yeast prion Sup35 (residues 7–13) (24), NFGAIL
from human IAPP (residues 22–27) (25), and DFNKF from
human calcitonin (residues 15–19) (26). This inspired
intensively experimental and theoretical, especially compu-
tational, simulation studies to uncover amyloidgenic protein
ﬁbril-formation processes (27–29) or predict the amyloid-
genic propensity of different sequences through short core
segments (30–32). For example, Melquiond et al. (33,34)
studied the mechanism of aggregation of the peptide KFFE,
which is the shortest one known to form amyloid ﬁbrils in
vitro. Lopez de la Paz et al. (35) investigated the de novo
designed amyloidgenic peptide STVIIE and its mutations by
molecular dynamics (MD). Additionally, there are also some
reports on the aggregation of the short peptide Ab16–22
(36,37). All these studies have improved our understanding
of the oligomer-formation mechanism of amyloidogenic
peptides to a certain extent.
The ﬁbrous microcrystal of heptapeptide GNNQQNY
from the yeast prion-like protein Sup35, determined by
Eisenberg and co-workers (21), reveals a parallel arrangement
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of b-strands perpendicular to the ﬁbril axis and provides a
good model to study the amyloid formation. For this peptide,
there have been several MD simulation studies on the very
early steps of the ﬁbril-formation event (38–40), the ther-
modynamic stability of different sizes of oligomers (41,42),
as well as the driving force of the ﬁbrillogenic association
(43). Gsponer et al. (39) observed that the parallel b-sheet
arrangement was favored over the antiparallel one due to
side-chain contacts by using implicit solvent MD simulations
with three peptides starting from random conformations and
orientations. Taking the crystal structure determined by
Eisenberg et al. as initial conformations, Zheng and co-
workers (42) studied the stability of the heptapeptide oligo-
mers with different sizes by explicit solvent MD simulations
and found that the parallel two-strand b-sheet is much more
unstable than corresponding trimers and tetramers. Then
how does the aggregation process occur from monomer to
dimer then to larger oligomers? In this study, all-atom MD
simulations with an explicit solvent model were performed
to investigate the oligomer-formation processes of the
heptapeptide GNNQQNY from monomer to tetramer by
adding one peptide at each step. Similar to Zheng et al.’s
simulations, we also found the parallel b-sheet dimers un-
stable, whereas antiparallel arrangement is more favored in
most of the dimerization simulations. However, from dimer
to trimer and tetramer, parallel stacking of newly introduced
strands were found to be more favored, which accords well
with the experimental matured microcrystal structure.
MATERIALS AND METHODS
All MD simulations were carried out by using the GROMACS 3.3 software
package (44,45) with constant number, pressure, and temperature and
periodic boundary conditions. -The GROMACS96 force ﬁeld (46) was
applied. The models were immersed in rectangular or cubic boxes ﬁlled with
water molecules with a distance between peptides and box edges of at least
10 A˚. A simple point-charge water model (47) was used for the solvent mol-
ecules in the simulations. The boxes’ sizes for monomer-, dimer-, trimer-,
and tetramer-formation simulations is 45 A˚3 25 A˚3 35 A˚, 60 A˚3 60 A˚3
60 A˚, 65 A˚3 65 A˚3 65 A˚, and 75 A˚3 75 A˚3 75 A˚, respectively, and the
corresponding number of water molecules are ;1045, 7080, 9010, and
13,670. The linear constraint solver (LINCS) method (48) was used to
constrain bond lengths, allowing an integration step of 2 fs. Electrostatic
interactions were calculated with the particle mesh Ewald algorithm (49,50).
The cutoff radius for the Lennard-Jones interactions was set as 10 A˚. The
simulations were performed at 300 K except that the monomer simulation
was set at 450 K. The Berendsen algorithm (51) has been applied for tem-
perature and pressure coupling. Most of the analyses were performed by
using facilities within the GROMACS package. Secondary structure
analyses were carried out employing the deﬁned secondary structure of
proteins (DSSP) method (52). All images were produced by using the
software PyMOL (53).
A 6 ns MD simulation of monomer at 450 K was ﬁrst performed with
initial coordinates taken from the x-ray crystal structure (Protein Data Bank
code 1YJP) (21) to sample all the possible conformations. The oligomer
formations from dimer to tetramer were performed by MD by adding one
peptide at each step, except for tetramer formation in which some initial con-
formations were the combination of two dimers. All the starting conforma-
tions are schematically shown in Fig. 1. In each initial structure of all the
simulations, the newly added peptide, possessing random conformation and
orientation, was extracted from the monomer MD trajectory, and the dimers,
trimers for trimer, and tetramer formation were extracted from dimer- or
trimer-formation trajectories. The distance of the two separated parts was
.10 A˚ at the beginning, as the cutoff of 10 A˚ for the Lennard-Jones
interaction was adopted. In this study, a total of 30 independent dimer-
formation simulations with each running for 50 ns, 20 independent trimer-
formation simulations with each running for 70 ns, and 21 independent
tetramer simulations (7 for each type of initial conformations) with each
running for 80 ns was carried out.
RESULTS
Dimer formation
In each of the 30 dimerization simulations, the two peptides
with random orientations and conformations, both extracted
from the monomer MD trajectory, were separated from each
other by at least 10 A˚ initially, as this distance was the cutoff
value for the Lennard-Jones interaction (see the Materials
and Methods section). Fig. 1 a shows the schematic initial
structure. Under the simulation conditions as described in the
Materials and Methods section, the two peptides moved
close to each other, then aggregated. The aggregation time
was estimated when the mass centers distance of the two
peptides decreased to,10 A˚, and it varied greatly from 2 ns
to 38 ns in the 30 simulations (Figure S1 in Supplementary
Material). As the analysis of secondary structure showed
FIGURE 1 The schematic initial structures
used in the simulation study. (a) For dimer for-
mation: two peptides with random conforma-
tions and orientations. (b) For trimer formation:
one antiparallel two-strand b-sheet extracted
from dimer-formation simulation and one mon-
omer. (c1–c3) For tetramer formation: (c1) one
antiparallel three-strand b-sheet from trimer-
formation trajectory and one monomer; (c2) one
three-strand b-sheet with two nearby parallel
strands and an antiparallel strand at one side and
one monomer; (c3) two antiparallel two-strand
b-sheets extracted from dimer-formation trajec-
tories.
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(Figure S2), after aggregation, most of the two peptides
formed obvious b-like structure. We also checked the num-
ber of backbone-backbone hydrogen bonds formed between
the two peptides (Figure S3) and found that in most cases,
when two peptides aggregate, backbone hydrogen interac-
tion between them begins to occur, and four hydrogen bonds
or more correspond to a b-sheet conformation.
In the 30 independent dimerization simulations, obvious
b-sheet structures were observed in 25 of them. Among these
25 simulations, 22 simulations gave antiparallel b-sheet di-
mers, most of which stayed until the end of the trajectories,
whereas parallel ones were observed in 4 of them. In one of
the simulations, a transition from parallel to antiparallel stack
was observed. The total occurrence time was ;406 ns and
52 ns for the antiparallel and the parallel alignment, respec-
tively. In both alignments, the distance between the two
peptide backbones is;4.5–5 A˚, which is consistent with the
distance of 4.87 A˚ determined by x-ray microcrystallography
(21). For the antiparallel dimers in the 22 simulations, there
were mainly two kinds of typical structures, as shown in Fig.
2. In the major structure type, the two strands matched
perfectly well (Fig. 2 a1), and in the minor one, there was a little
sliding between two strands along the backbone (Fig. 2 a2).
In one of the simulations, a transition from parallel to
antiparallel alignment was observed. As shown in Fig. 3, at
;19.2 ns, the two peptides arranged in parallel at one end
(Fig. 3 a); after another 7.5 ns, the b-like structure began to
deteriorate (Fig. 3 b); then at ;36.4 ns, an antiparallel ar-
rangement was formed (Fig. 3 c). Although this transition
was observed only in one of the simulations, when we ex-
tracted two of the parallel b-like structures formed in trajec-
tories as initial ones to carry out another two independent
40 ns MD simulations, this parallel to antiparallel arrange-
ment transition was observed in both of the new simulations.
Therefore, we believe that the antiparallel dimer might be
easier to form than the parallel one for this heptapeptide.
Trimer formation
The schematic starting structures for trimer-formation sim-
ulations were shown in Fig. 1 b, which were built by putting
an assembled antiparallel b-sheet dimer (selected from the
above dimer-formation simulations) and a new peptide with
random conformation and orientation (from monomer sim-
ulation) into the water box with their separation distance of at
least 10 A˚. Twenty independent 70 ns MD runs were per-
formed. Secondary structure analysis showed that the new
peptide arranged along the two-strand b-sheet in parallel
alignment in 6 of the 20 simulations and in antiparallel
alignment in 8 of them. In one simulation, both parallel and
antiparallel alignments were observed, that is, a transition
from parallel to antiparallel arrangement occurred. The rest
of the simulations exhibited disordered aggregates or the
newly introduced strand just congregated with the dimer
irregularly. Altogether, parallel and antiparallel structures
were observed to stay for ;285 ns and 112 ns in all 20
simulations, respectively, and both of the typical b-like
structures were shown in Fig. 2, b1 and b2. Obviously, the
duration of the parallel alignment is much longer than the
antiparallel one.
As the aggregation time was controlled by the diffusion of
the two separate groups in water and the congregated time
varied signiﬁcantly in different simulations, how long did it
take for the aggregates from disorder to become regular
b-like structures? Here, we deﬁne a parameter t termed
‘‘b-like structure-formation time’’, which is the difference
between b-like structure appearing time and the time of
peptides aggregation,
FIGURE 2 The typical b-sheet structures formed in the oligomer simu-
lations. Dimer: (a1) the two strands matched well; (a2) a slide along the
backbones between the two strands. Trimer: the new strand stacked in parallel
(b1) and in antiparallel (b2) arrangement. Tetramer: the new strand aligned in
parallel (c1-p, c2-p, and c3-p) and in antiparallel (c1-a, c2-a, and c3-a) arrange-
ment. The secondary structure of the new strand is represented inmagenta and
that of the others is represented in green.
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t ¼ the time theb-like structure appeared
 the time of aggregation:
b-like structure appearing time was measured by second-
ary structure analysis. Meanwhile, the time of aggregation
was determined by when the mass centers distance of two
parts was ,10 A˚. Fig. 4 gives one typical example of mass
centers distance measurement of two separated parts and the
secondary structure analysis to determine b-like structure-
formation time. When comparing the values of this param-
eter in the simulations where regular three-strand b-sheets
formed, as shown in Table 1, we found that for parallel
arrangement of the newly introduced strand, the values were
remarkably smaller than those for antiparallel arrangement,
with an average of 6.7 ns vs. 23.5 ns, although the ﬂuctuation
was evident.
Therefore, the trimer-formation simulations showed that
parallel increment structure forms faster and stays longer
than antiparallel structure.
Tetramer formation
Simulations on the tetramer formation were started from
three types of conformations as shown in Fig. 1, c1–c3. The
ﬁrst one was constructed by adding a new peptide with
conformation from the monomer trajectory and one antipar-
allel three-strand b-sheet from trimer-formation trajectories
(Fig. 1 c1). The second one was constructed with a three-
strand b-sheet with two nearby parallel strands and an
antiparallel strand at one side, adding a new monomer with
random structure (Fig. 1 c2). The third one consisted of two
two-strand antiparallel b-sheets from dimer-formation tra-
jectories (Fig. 1 c3). For each type of the initial structures,
seven independent 80 ns MD runs were performed.
In 11 of the 21 simulations, regular four-strand b-sheet
structures were observed, including parallel alignment of the
newly introduced peptides in 7 simulations (four initial
structures like that in Fig. 1 c1, two like that in Fig. 1 c2, and
one like that in Fig. 1 c3) and antiparallel alignment in 5
simulations (one initial structure like that in Fig. 1 c1, two
like that in Fig. 1 c2, and two like that in Fig. 1 c3). In one
simulation, the transition from parallel to antiparallel was
observed. Altogether, parallel and antiparallel alignment
lingered ;175 ns and 128 ns, respectively, and Fig. 2, c1-p–
c3-p and c1-a–c3-a, showed the typical regular structure
snapshots observed in these trajectories. We also estimated
the b-like structure-formation time t as mentioned above in
the trimer-formation simulations, and the results are also
listed in Table 1. It is obvious that the values of t for parallel
arrangement of the newly introduced peptide are also smaller
than those for antiparallel ones, with an average of 4 ns
compared to 25.8 ns. Although the deviation from the
average values is large, this obvious difference indicates that
the newly added peptide might prefer parallel increment to
the existing b-sheet kinetically.
In the tetramer-formation simulations, a two-layered
structure with one extended strand aligning along the side
of a three-strand b-sheet, as shown in Fig. 5, was observed
distinctly in 4 of the 21 simulations. The side strand stacked
in parallel to the middle one of the three-strand b-sheet in
FIGURE 3 Representative snapshots of the
transition from parallel to antiparallel arrange-
ment in one dimer-formation trajectory. (a) At
19.27 ns, the parallel arrangement was formed at
one end; (b) the parallel packing was destroyed
at ;26.8 ns; (c) at ;36.4 ns, the two-strand
packed in antiparallel alignment. Only the
residue tyrosine is presented in line.
FIGURE 4 Example for b-like struc-
ture-formation time deﬁnition. (a) The
change of mass center distance of two
separated groups along with time (if
this distance is ,10 A˚, the two groups
are considered to form an aggregation);
(b) the change of secondary structures
along with time. The b-like structure-
formation time is determined by the
difference of the two values obtained in
(b) and (a). Secondary structures were
analyzed using DSSP, and b-sheet
structures are shown in magenta.
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one of the four simulations and in antiparallel in the other
three simulations. On average, the two layers were separated
by ;8 A˚, very close to the 8.5 A˚ determined in microcrystal
structure (21). In this kind of conformation, the complemen-
tary shape formed by side-chain amide groups has been
observed in some snapshots, just as shown in Fig. 5, d and e,
which is also similar to the observation in the microcrystal
structure (21). For each of the four simulations, the root
mean-square deviation (RMSD) of backbone atoms, with the
most perfect two-layered conformation in each trajectory as
reference, was monitored (shown in Figure S4). The total
time for RMSD value .0.3 nm was ;78 ns, showing that
this kind of conformation lingered for considerable time.
Therefore, the second layer might start from tetramers in
ﬁbril oligomer formation.
p-p stacking of Tyr side-chain groups
As there is an aromatic residue Tyr in this hexapeptide, we
also monitored the p-p stacking conformation in the simula-
tions. Three criteria were used to deﬁne a p-p stacking
conformation. The distance of the two aromatic rings’ geo-
metrical centers should be ,6 A˚. The angle between the
planes of the two aromatic rings should be ,45. The angle
between two vectors—one is the average of the two normal
vectors to the two aromatic ring planes, the other is the
coordinate vector of two aromatic ring geometric centers—
should be ,60. We monitored the p-p stacking confor-
mation that satisﬁed all three criteria in the dimer- and
trimer-formation simulations.
For dimer formation, in 11 of all the 25 simulations where
b-sheet-like structure was observed, the occurrence time for
p-p stacking of Tyr residues was .1 ns, and with a total
time of 70 ns for all the 11 trajectories. This structure
appeared not only in the irregular aggregates (statistically
;19 ns) but also in the duration of b-sheet formation
(statistically ;51 ns). Fig. 6, a1 and a2, showed the typical
examples of p-p stacking in these two cases.
Meanwhile, for trimer formation, there were 13 simula-
tions in each of which after the two separate parts
aggregated, the occurrence time of p-p stacking conforma-
tion was.1 ns. There were mainly two cases. One was in the
three-strand b-sheet where the introduced strand stacked in
parallel alignment (totally 41 ns or so), as the typical
example shows in Fig. 6 b1. The other was in the aggregates
where the newly introduced strand had not been aligned
along the dimer regularly, but its residue Tyr touched one of
the dimers and formed a p-p stacking structure with it (in
total 27 ns or so), as shown in Fig. 6 b2. In the latter, the event
occurred in the simulations where eventually the newly
introduced strand increased in parallel (duration of the p-p
stacking conformation;10.2 ns), antiparallel (duration;7.9
ns), as well as irregular arrangement (duration ;8.8 ns). It
shows there is no preference for the parallel increment pattern
in this case.
Twisting b-sheet conformation
Twisting b-sheet conformation was also observed in many
snapshots of dimer-, trimer-, and tetramer-formation processes,
TABLE 1 The b-like structure-formation time in trimer- and tetramer-formation simulations
Oligomers Arrangement of new peptide b-like structure formation time (ns) Average (ns)
Trimers Parallel 1, 10, 14, 11, 2, 2 6.7 6 5.1
Antiparallel 39, 17, 44, 18, 3.5, 15, 28 23.5 6 13.2
Tetramers Parallel 2(c1), 0(c1), 0(c1), 18(c1), 2(c2), 2(c2), 4(c3) 4.0 6 5.8
Antiparallel 12(c2), 17(c2), 52(c3), 22(c3) 25.8 6 15.5
c1–c3 represent simulations corresponding to different initial structures in Fig. 1.
FIGURE 5 The schematic structures of the
two-layered conformation observed in tetra-
mer-formation simulations. (a–c) The sche-
matics from the view of three orthogonal
directions and only main chains are shown,
in (c) the distance between the two layers is
presented ;8 A˚; (d) and (e) are representative
conformations of the side strand and the middle
one of the three-strand b-sheet (the other two
strands within the sheet were hidden) in two
independent trajectories, which displayed ob-
viously complementary shape between the two
peptides’ side-chain groups. The pink repre-
sented the side strand, and the green repre-
sented the strands in three-strand b-sheet.
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as the typical schematic examples show in Fig. 7. This
indicates that the twisting b-sheet conformation might start
from the beginning of the ﬁbril formation, that is, the grow-
ing process of very small oligomers.
DISCUSSION
The atomic structure of the cross-b spine of the seven-
residue peptide GNNQQNY from Sup35 was determined by
Eisenberg and co-workers from its closely related micro-
crystals (21), which provides important information for
amyloid-formation studies. The structure contains a double
b-sheet and the parallel segments stack in register within
each sheet. Taking conformations from the crystal structures,
Zheng et al. performed all-atom explicit solvent MD
simulations of various sizes of the peptide oligomers to
investigate their stability (42). They found that the parallel
two-strand b-sheet conformations were unstable when
simulated alone, whereas the parallel b-sheet containing
more than two strands were much more stable. Then how do
the peptides form the ﬁbrous oligomers from monomers?
What kind of dimer conformation should be developed ﬁrst?
We have tried to answer this question in this study. In our
dimer-formation MD simulations of this peptide, 22 of the 30
independent trajectories displayed the antiparallel arrange-
ment b-sheet. Furthermore, in one simulation, a transition
from parallel to antiparallel alignment was observed. Two
additional simulations starting from parallel conformations
extracted from the dimer-formation trajectories also showed
the same transition. These results are consistent with Zheng
et al.’s simulations, which show that the parallel dimers are
unstable, implying that the nucleation of amyloid ﬁbrils
might start from the antiparallel dimer structure. Although
the extended regular b conformation might not be the most
energetically stable structure, it can serve as a template to
bind new peptides. Thus the kinetically trapped state might
be metastable intermediates which play an important role
in the formation of early aggregates, just as discussed by
Hwang et al. (28).
Many studies have reported on the dimer formation of
various short peptides, not only from a kinetic point of view
(28,54) but also from a thermodynamic one (55–57). For
some peptides, such as Ab16–22, thermodynamic investiga-
tion (56) showed its free energy surfaces were complicated,
and diverse states with low energy were captured. Although
for the GNNQQY peptide, as we focused mainly on its ag-
gregation mechanism, the question of whether the antipar-
allel dimer preponderantly trapped in the simulations should
accompany a complete downhill proﬁle in the free energy
surface would need a further thermodynamic study. The dif-
ferent sequence characteristics of the peptide GNNQQNY,
which is hydrophilic and comprises no charged residues,
may bring some differences compared to those peptides with
hydrophobic or electrostatic interactions playing dominating
roles in the oligomer assembling process.
Although the soluble oligomer intermediates were thought
to be cytotoxic, their formation mechanism is still obscure.
Our dimer simulations showed that the two peptides pre-
ferred to form antiparallel arrangement, then how do the
dimers increase into trimer then tetramer and then form a
cross-b-sheet ﬁbril with parallel strands within each sheet?
We simulated the trimer- and tetramer-formation process by
adding one new peptide to the assembled regular dimer at
each step. In these simulations, both parallel and antiparallel
alignments of the new peptide were observed. The lingering
time of the two patterns was monitored. As indicated by
Hwang et al.’s study (28), the dimer structure might be con-
trolled by kinetics; the same might be true for the oligomers
like trimer or tetramer. If one type of regular conformation
could hold longer than others, then it might have more
chances to continue the aggregation. This did occur to the
parallel increment in our trimer and tetramer simulations.
The other monitor was the comparison of the b-like
FIGURE 6 The representative p-p stacking conformations in dimer-
formation simulations: (a1) irregular dimer aggregate and (a2) antiparallel
b-sheet dimer, and in trimer-formation simulations: the newly introduced
strand (b1) arranged in parallel and (b2) coalesced irregularly. The tyrosine
residues forming p-p stacking were represented by stick in orange, and
other residues were characterized in green.
FIGURE 7 The typically schematic twist
structures in (a) dimer, (b) trimer, and (c) tetra-
mer aggregates.
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structure-formation time, that is, the transition time of aggre-
gates from disorder to regular structure, which also sug-
gested that the parallel alignment was more favorable than
the antiparallel one, as for the former, the formation time was
apparently shorter.
Therefore, although the number of trajectories for the
parallel increment is almost the same as that for the
antiparallel one, the two monitors showed that new peptide
might add in parallel arrangement more easily, which agrees
with the microcrystal structure determined by Eisenberg and
co-workers in which the strands are parallel within the
b-sheet of the ﬁbril. Gsponer and co-workers (39) performed
implicit solvent MD simulations of this peptide starting from
three peptide replicas with random conformations, positions,
and orientations. They observed a more stable parallel two-
strand sheet and all parallel three-strand b-sheet, so they
concluded that the parallel b-sheet arrangement is favored
over the antiparallel one. The differences between their
simulations results and ours might primarily come from the
different solvent models used. Instead of the implicit solvent
model they used, we adopted an explicit water model, as the
important role of water molecules has been reported (58,59).
Another reason might arise from the secondary structure bias
of different force ﬁelds, as some studies have shown that the
CHARMM22 is a-helix biased and GROMOS force ﬁeld is
b conformation biased (60,61). This force ﬁeld b-sheet bias
may inevitably drive aggregates toward the ordered b-sheet
forms, whereas because our effort is to investigate the preva-
lence of parallel versus antiparallel species and their roles in
amyloid ﬁbril formation and because the peptide conforma-
tions are almost identical in parallel and antiparallel b-sheets,
the force ﬁeld bias is not expected to play major roles here.
As the model peptide GNNQQNY is quite hydrophilic,
the driving force for oligomer formation should not be
hydrophobic interactions as for those highly hydrophobic
peptides. Zheng et al. suggested that the driving force might
be interstrand backbone-backbone and side-chain side-chain
hydrogen bonds within sheet and shape complementary of
side chains between sheets (42). Fernandez and co-workers
demonstrated that the dipole-dipole interactions play an
important role (43). The formation of antiparallel dimer and
then parallel increase in our simulations may also come from
the interstrand backbone-backbone hydrogen bonds and
side-chains interactions. Other studies have shown that p-p
stacking of aromatic residues plays an important role in the
formation of amyloid ﬁbril structures (17,20,39,40,62–65).
Some investigators (62,63,65) proposed that interactions
between aromatic residues not only contribute signiﬁcantly
to the thermodynamic stability of the amyloid structures but
also provide order and directionality in the self-assembly.
For the peptide GNNQQNY, if it is true, the p-p stacking
conformation should be favorable in parallel alignment.
Although, in this study, as described in the ‘‘p-p stacking of
Tyr side-chain groups’’ section, in dimer-formation simula-
tions, this kind of conformation was exhibited not only in
antiparallel b-sheet structure, but also in the aggregates
before the b-sheet formation, that is, the p-p stacking does
not help the strands’ arrangement in parallel. Moreover, in
trimer-formation processes, before the regular structure
formed, the p-p stacking structure was observed both in
those parallel increase and those antiparallel increase trajec-
tories, as well as the irregularly aggregates ones, which
indicates that aromatic residues may not play an important
role in giving directionality to the oligomer-formation
process. However, this conformation exhibited a consider-
ably long duration in those parallel increase simulations
(almost 41 ns as described previously), which suggests that
the aromatic residues might have a considerable inﬂuence on
the stability of the oligomeric b-sheet structure formed.
Gsponer et al. (39) also indicated that aromatic residue does
not give directionality to the self-assembly process but
stabilizes the parallel aggregates.
It is worth mentioning that, in our simulations, the twisting
b-sheet structure was observed in dimer, trimer, and tetramer
structures. The twisting structure in amyloid ﬁbrils has been
reported in a number of experimental and modeling studies
(41,66–68). So our results imply that the twisting b-sheet
conformation might begin with the oligomers, even a dimer.
Additionally, the two-layered structure was observed lin-
gering considerable time in tetramer-formation simulations,
and the complementary conformation of side-chain groups
agreed well with the microcrystal structure, suggesting the
new layer for the oligomers might start from tetramer ag-
gregates.
In the simulations here, the transition from one aligned
pattern to another was observed only in three of the simula-
tions (in dimer, trimer, and tetramer formation, respectively).
Furthermore, as the number of simulations was limited due
to the limitation of computational power for the all-atomic
molecular dynamics with the explicit solvent model, the statis-
tical results were only qualitative. More simulation trajecto-
ries with more statistical events may generate better results.
In summary, we have investigated how the small oligo-
mers were formed in the amyloid ﬁbril-formation process of
the peptide GNNQQNY from the yeast prion-like protein
Sup35 by molecular dynamics simulations. Our simulations
suggested that the antiparallel dimer may form ﬁrst, then new
peptides may add to the assemblies in parallel arrangement.
Possible reasons for why parallel dimer is not stable and
parallel trimers and tetramers are stable were discussed.
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